A member asked:

Hello, shall i allways have zometa and herceptin (trastuzumab) for her 2 breast cancer bone metastasis? or, is zometa with femara enough? thanks a lot

A doctor has provided 1 answer
Dr. Le Wang answered

Specializes in Internal Medicine

Her2-pos Breast Ca: Herceptin (trastuzumab) is indicated for Her2-pos metastatic BC. Duration of therapy in metastatic setting is not well defined. Usually it continues as long as it works or discontinued due to toxicity. Zometa is indicated for bone metastasis in most solid tumors. It carries a risk for osteonecrosis of jaw. Usually it is stopped after 2 yrs if not earlier. Femara is for post-menopausal BC who has positive ER/PR.

Answered 3/13/2015

3.1k views

Thank

Related Questions